Specific changes in the levels of circulating cell-free mitochondrial DNA in the serum of patients with diabetic microangiopathy
Laboratory Medicine · 2025
DOI: 10.1093/labmed/lmaf034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2025. Verfasst von Shuhan Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Technology, Beihua University, Jilin, China. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Cell-Free Nucleic Acids, Diabetic Angiopathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Jilin Province People's Government, China, Jilin Scientific and Technological Development Program, China, Jilin Province People’s Government, China.
Abstract (Originalsprache)
Introduction
Diabetic microangiopathy (DMAP) is a common chronic complication of diabetes. This study aimed to explore the early diagnostic value of the copy number and methylation level of cell-free mitochondrial DNA in the serum of patients with DMAP.
Methods
A total of 40 patients with simple diabetes (diabetes group) and 50 patients with DMAP (40 with diabetic nephropathy [DN group] and 10 with diabetic retinopathy [DR group]) were included in the study. The copy number and methylation levels of cell-free mitochondrial DNA in serum were examined using real-time polymerase chain reaction and high-resolution melting curves.
Results
The serum copy number of cytochrome b (Cytb), NADH dehydrogenase subunit 6 (ND6), and displacement loop (DLoop) genes statistically significantly increased in the DN and diabetes groups compared with the healthy control group (P < .001). The high-resolution melting curve results showed that the degree of methylation of ND6 decreased with the progression of DMAP compared with that in the health control group (P < .001). There was a statistically significant increase in the methylation degree of the DLoop genely in both the DN and DR groups compared with both the health control and diabetes groups (P < 0.001).
Discussion
The copy number of the Cytb, ND6, and DLoop genes in patients with DMAP differed from that in the healthy control group. Mitochondrial DNA methylation of ND6 and DLoop may be a novel potential biomarker of DMAP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medical Technology, Beihua University, Jilin, China.
- Jilin Municipal Hospital of Traditional Chinese Medicine, Jilin, China.
Förderung
- Jilin Province People's Government, China
- Jilin Scientific and Technological Development Program, China
- Jilin Province People’s Government, China
Zitieren
APA
Dong, S., Wang, H., Zhou, X., Zhang, Z., Zhan, X., Jin, Z., Yang, S., Xia, W., & Liu, L. (2025). Specific changes in the levels of circulating cell-free mitochondrial DNA in the serum of patients with diabetic microangiopathy. Laboratory Medicine. https://doi.org/10.1093/labmed/lmaf034
Vancouver
Dong S, Wang H, Zhou X, Zhang Z, Zhan X, Jin Z, et al. Specific changes in the levels of circulating cell-free mitochondrial DNA in the serum of patients with diabetic microangiopathy. Laboratory Medicine. 2025. doi:10.1093/labmed/lmaf034
BibTeX
@article{Dong2025,
author = {Dong, Shuhan and Wang, Helin and Zhou, Xinchen and Zhang, Zhuo and Zhan, Xingtong and Jin, Zhuo and Yang, Shuhui and Xia, Wei and Liu, Limei},
title = {Specific changes in the levels of circulating cell-free mitochondrial DNA in the serum of patients with diabetic microangiopathy},
journal = {Laboratory Medicine},
year = {2025},
doi = {10.1093/labmed/lmaf034}
}
EUVIMED